Evidence map›Paper›PMID 42267378›Full record

ArticleERJ open research2026

Treatment response trajectories for speech pathology intervention in chronic cough.

Yuto Hamada, Jordan Jeffery, Peter G Gibson, Anne E Vertigan

Abstract read
In one paragraph

Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuto HamadaCentre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, The University of Newcastle, Newcastle, Australia.
Jordan JefferyCentre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, The University of Newcastle, Newcastle, Australia.ORCID https://orcid.org/0009-0005-1182-7374
Peter G GibsonCentre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, The University of Newcastle, Newcastle, Australia.
Anne E VertiganCentre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, The University of Newcastle, Newcastle, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Speech pathology intervention is an effective treatment for refractory and unexplained chronic cough (RUCC); however, data regarding treatment outcomes in real-world settings are limited. Similarly, the influence of cough phenotypes on treatment response variability is unknown. This study aimed to 1) identify trajectories of response to speech pathology intervention and 2) determine predictors of treatment response trajectories. Methods: The medical records of 205 participants referred to speech pathology for assessment and management of RUCC were reviewed. Data included demographics, medical comorbidities, appointment dates, Leicester Cough Questionnaire (LCQ) scores and clinical outcome. Participants with three or more LCQ scores were included in the analysis. A growth mixture model was used to estimate participant treatment response trajectories and logistic regression models identified baseline predictors of trajectory membership. Results: Three treatment response trajectory groups were identified: Severe Cough-Slow Response (21%), Severe Cough-Rapid Response (23%) and Moderate Cough-Slow Response (56%). Asthma diagnosis (p=0.034) and baseline LCQ score (p≤0.001) were predictors of trajectory group. Most patients (76%) achieved improvement exceeding the LCQ minimally clinically important difference. Notably, the Severe Cough-Rapid Response group demonstrated marked improvement in LCQ score with a shorter treatment duration (median 56 days). Conclusions: This novel application of trajectory analysis to investigate treatment response to speech pathology intervention in RUCC supports the heterogeneous nature of RUCC. We identified a group with severe cough who demonstrated a faster and greater treatment response. Our findings demonstrate the effectiveness of speech pathology intervention and support further exploration of cough phenotyping.

Identifiers

PMID42267378
PMCPMC13244209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.